Thanks . External data sources indicate that over 56,000 people...

Thanks . External data sources indicate that over 56,000 people each year in the USA, Australia and Japan are diagnosed with conditions that fall into Control Bionics key target user base. Based on the Company’s average revenue per unit in FY20 of A$21,928 this implies an annual market opportunity of approximately $1.2 billion. Even with a 40% margin equates to a huge upside . Personally I have a 2 year time frame at minimum before I will reassess. I prefer the stock doesn’t move in the next 6-12 months . Buy and hold for more than 12 months . Less CGT.